HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

FILE – Abortion-rights activists holds a signs as they protest outside of the Supreme Court during a rally on March 26, 2024, in Washington. (AP Photo/Jose Luis Magana, File) By Associated Press ...

A new report finds that the number of abortions in the U.S. grew in 2024 as more women obtained pills through telehealth.

Four states petitioned the Food and Drug Administration on Thursday to lift its lingering restrictions on abortion pills. The attorneys general of California, Massachusetts, New Jersey and New ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed Wednesday that he has ordered the Food and Drug Administration (FDA) to conduct a “complete review” of a chemical abortion ...

Attorneys general of New York, California, New Jersey and Massachusetts are asking the Food and Drug Administration (FDA) to expand access to the abortion pill and remove some “unnecessary ...

Attorney generals from four pro-abortion states have filed a petition asking the FDA to lift restrictions on abortion pill ... Health and Human Services Secretary Robert F. Kennedy Jr., ...

RFK Jr. is prepared to rework the FDA’s official assessment of the abortion pill mifepristone based at least in part on a questionable report.

Hardline anti-abortion movement leans into 'manhood' debate to broaden appeal A small network of anti-abortion rights activists has been making progress pushing for bills that would classify ...

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues … ...